TECLens Closes $10 Million Series A2 Extension Financing, Tags New CEO
STAMFORD, Conn.—TECLens, Inc., a clinical-stage ophthalmic medical device company focused on non-invasive vision correction, has announced the closing of a $10 million Series A2 extension financing. The financing…





